FREDERICK, Md., June 8, 2026 /PRNewswire/ -- The Frederick Arts Council (FAC) invites artists to submit proposals for two sculptural pedestals for permanent installation...
Robbins LLP is Investigating Allegations that Sportradar Group AG (SRAD) Intentionally Worked with Black-Market Gambling Operators as a Business Strategy
COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.
NEWARK, Calif., June 8, 2026 /PRNewswire/ -- Lucid Group, Inc. (NASDAQ: LCID), maker of the world's most advanced software-defined vehicles and technologies, today announced...
BRADENTON, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (Nasdaq: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the appointment of Ashlee Weisser to Chief Financial Officer effective June 8, 2026. She succeeds Mel Hope, who announced his planned retirement earlier this year and will continue to serve in an Advisor role to support a seamless leadership transition.
First Quarter Revenue Grows 50% to $52.8 Million; Net Income Increases 66% to $2.1 Million with Adjusted EBITDA Up 71% to $4.9 Million; Cash Position Grows to $24.4 Million
Company Establishes Majority-Owned U.S. Subsidiary to Commercialize Modular Gas-to-Electricity Generation Systems for AI Data Centers and Other Energy-Intensive Applications Across North AmericaCHANGZHOU, China, June...
FLOWER MOUND, Texas, June 08, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated(NASDAQ: MTEX) announces that on June 3, 2026, Yasir Haider was appointed Chief Financial Officer of Mannatech, Incorporated (the "Company").
ZUG, Switzerland, June 08, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the 47th Annual Goldman Sachs Global Healthcare Conference.